// App-Quantinova.ai

ISC35 2016 BOS : Effect of Idarucizumab on Intracranial Bleeding in Dabigatran-treated Patients: Initial Results From RE-VERSE AD

Researchers

Presenter

  • Charles V Pollack

Principal Investigators

  • Philip B Miner

  • Jeffrey I Weitz

  • Paul A Reilly

  • John Eikelboom

  • Menno V Huisman

  • Pieter W Kamphuisen

  • Jorg Kreuzer

  • Jerrold H Levy

  • Thorsten Steiner

Medical Centers

  • Northwestern University, Chicago, IL

  • McMaster University, Hamilton, ON, Canada

  • University Clinic Heidelberg, Heidelberg, Germany

  • Leiden University Medical Centre, Leiden, Netherlands

  • Duke Univ Med Ctr, Atlanta, GA

  • Medical Center Groningen, Groningen, Netherlands

  • Thomas Jefferson University, Philadelphia, PA

Locations

  • United States

  • Canada

  • Germany

  • Netherlands

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Non-valvular atrial fibrillation

  • Hematoma

  • Stroke

Biomarkers

  • Collagen type IV alpha 2 chain

Drug/Treatment

  • Idarucizumab

  • Pradax

  • Evithrom

  • Warfarin

Outcome

  • N/A

Study Design

  • open label

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved